Roivant Sciences, Inc. (Nasdaq: ROIV) announced the successful pricing of an upsized public offering of 26,666,666 of its common shares at a price of $7.50 per share. The offering represents an impressive $200 million in gross proceeds, with the underwriters also being granted a 30-day option to purchase up to an additional 3,999,999 common shares. The offering is expected to close on February 7, 2023, subject to customary closing conditions.
The U.S. Securities and Exchange Commission declared a registration statement on Form S-3 effective on October 3, 2022, providing a pathway for the offering of common shares. To learn more about this opportunity, investors can view the prospectus supplement and accompanying prospectus by visiting the SEC’s EDGAR website, where they can access the documents free of charge. This is a unique opportunity to invest in a promising future.
Investors interested in obtaining a free copy of the final prospectus supplement and accompanying prospectus for the offering can do so from any of the following: Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC, or Cantor Fitzgerald & Co. All you need to do is contact the respective party’s Syndicate Department, Prospectus Department, or Capital Markets team at the respective addresses listed.
We are pleased to announce an opportunity to invest in our securities. All offers, solicitations, or sales of the securities will comply with the registration requirements of the Securities Act of 1933, as amended. Don’t miss out on this chance to be part of our success story!
About Roivant Sciences
At Roivant, we’re on a mission to revolutionize the healthcare industry. We believe that every inefficiency is an opportunity to create transformative medicines and health technologies faster and more effectively. That’s why we’ve developed the Roivant platform, which allows us to launch “Vants” – agile and focused biopharmaceutical and health technology companies that are committed to delivering the best possible care to patients. Our goal is to make healthcare more accessible, more efficient, and more effective for everyone.